Compare SLBT & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLBT | MAX |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 644.9M | 657.4M |
| IPO Year | 2025 | 2020 |
| Metric | SLBT | MAX |
|---|---|---|
| Price | $0.54 | $13.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $15.86 |
| AVG Volume (30 Days) | 46.5K | ★ 1.1M |
| Earning Date | 10-26-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.81 |
| EPS | N/A | ★ 1.32 |
| Revenue | N/A | ★ $1,113,600,000.00 |
| Revenue This Year | N/A | $22.43 |
| Revenue Next Year | N/A | $10.60 |
| P/E Ratio | ★ N/A | $10.48 |
| Revenue Growth | N/A | ★ 28.78 |
| 52 Week Low | $0.57 | $7.09 |
| 52 Week High | $6.25 | $15.99 |
| Indicator | SLBT | MAX |
|---|---|---|
| Relative Strength Index (RSI) | 22.09 | 53.01 |
| Support Level | N/A | $13.68 |
| Resistance Level | $1.75 | $14.42 |
| Average True Range (ATR) | 0.13 | 0.80 |
| MACD | -0.01 | -0.19 |
| Stochastic Oscillator | 4.94 | 7.05 |
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.